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Abstract 
Background: The Morel-Lavallee Lesion (MLL) is a closed degloving injury most 
commonly described in the region of the hip joint after blunt trauma. We have observed 
that the MLL also occurs in the knee as a result of shearing trauma during football, and is 
a distinct lesion from prepatellar bursitis and quadriceps contusion. 
 
Purpose: To review our experience with MLL of the knee in the elite contact athlete, in 
order to construct an evidence-based diagnostic and treatment algorithm. 
 
Methods: Twenty-seven knees in 24 players were identified from one National Football 
League team’s annual injury database as having sustained a MLL between 1993 and 
2006. Their charts were retrospectively reviewed for demographic information, injury 
history, physical examination, treatment, outcome and time missed from participation. 
 
Results: The most common mechanism of injury was a shearing blow to the knee on the 
playing surface (81%). The most common motion deficit was active knee flexion (41%). 
The consistent examination finding was a large area of palpable fluctuance extending 
from the patella to the mid-thigh, with variable medial and lateral extension. The MRI 
characteristically demonstrated normal musculature, with fluid in the potential space 
between the subcutaneous fat and underlying quadriceps fascia, extending to the mid-
coronal plane and mid-thigh. The average time for resolution of the fluid collection and 
achievement of full active knee flexion was 16.3 ± 18.0 days. The average number of 
practices missed was 1.5 ± 1.5. The average number of games missed was 0.1 ± 0.3. 
Fourteen knees (52%) were treated successfully with compression wrap, cryotherapy and 
motion exercises alone. Thirteen knees (48%) were treated with at least one aspiration, 
and six knees (22%) were treated with multiple aspirations for recurrent serosanguinous 
fluid collections. The average amount of fluid yielded was 46 ± 29 ml from the first 
aspiration, and 77 ± 53 ml for each subsequent aspiration. In three cases (11%), the MLL 
was successfully treated with Doxycycline sclerodesis after three aspirations failed to 
resolve the recurrent fluid collections; return to play was immediate thereafter in each 
case. There were no infections or adverse affects observed after any aspiration or 
sclerodesis.  
 
Conclusion: In football, MLL of the knee usually occurs from a shearing blow to the 
playing field. Diagnosis is confirmed when examination reveals a large suprapatellar area 
of palpable fluctuance, and MRI demonstrates a subcutaneous fluid collection extending 
to the mid-coronal plane and into the thigh proximally. Elite athletes are typically able to 
return to practice and game play long before complete resolution of the lesion. Recurrent 
fluid collections can occur, necessitating aspiration in approximately half the cases for 
successful treatment. Recalcitrant fluid collections can be safely and expeditiously treated 
with Doxycycline sclerodesis. Protective knee padding may decrease the incidence of 
MLL. 
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Introduction 
 
The Morel-Lavallee Lesion (MLL) is a post-traumatic soft tissue injury first described by 
the French Physician Maurice Morel-Lavallee in 1853. The lesions most commonly occur 
in association with pelvic and acetabular fractures, but can also occur from low-velocity 
crush injury.21,35 Deforming forces of pressure and shear result in a closed soft-tissue 
degloving injury, in which the skin and subcutaneous tissue are separated from the 
underlying fascia, disrupting the perforating vessels. The space created can fill with 
blood, lymph and necrotic fat, potentially leading to bacterial colonization and infection. 
Pseudocysts can form at the site of the original lesion, resulting in recurrent fluid 
accumulation.11,19-21 Missed diagnosis can lead to delayed presentation as a contour 
deformity due to local tissue necrosis.14  Morel-Lavallee lesions have most commonly 
been reported to involve the soft-tissues surrounding the greater trochanter, the flank and 
the buttock.11,12,21,34,35 To our knowledge, MLL of the knee has not been reported as a 
result from athletic competition. 
 
Historical treatment of a MLL involved open serial debridement with subsequent healing 
by secondary intention.11,19 Recently, there has been a trend towards less invasive 
approaches. Successful treatments for MLL in the thigh, buttock and flank have included 
elastic compression bandage; percutaneous drainage with debridement, irrigation and 
suction drainage; and liposuction or drainage followed by pressure therapy.12,18,34,35 These 
approaches aim to minimize iatrogenic soft-tissue trauma and disruption of the remaining 
vascular supply to the skin over the lesion, while achieving rapid healing and favorable 
cosmesis.13 In cases of recalcitrant fluid collections caused by pseudocyst formation, talc 
sclerodesis has been effectively utilized.22  
 
We report on our experience with MLL of the knee sustained from participation in 
National Football League. The principles of our management approach are in general 
accordance with published literature on post-traumatic MLL in the hip region. However, 
closed degloving injury of the knee in the elite contact athlete poses unique challenges, 
particularly when requiring invasive management for expeditious resolution and return to 
play. We aim to create an evidence-based diagnostic and treatment algorithm based upon 
the data presented. 
 
Methods 
 
Twenty-seven knees in 24 players were identified from one National Football League 
team’s annual injury database as having sustained a MLL between 1993 and 2006. Their 
charts, comprised of detailed examination and treatment notes from the team physician 
and training staff, were retrospectively reviewed. Demographic information gathered 
included side of injury, age at injury, player position, mechanism of injury, time to 
evaluation, physical examination findings and treatment course. Outcome data acquired 
included time missed before return to practice and games, time to resolution of the fluid 
collection and time before presence of full knee motion. This information was used to 
create an algorithm for the diagnosis and treatment of MLL of the knee in the contact 
athlete. 
  
Results 
 
Twenty-seven knees in 24 football players were found to have sustained a MLL between 
1993 and 2006. Fourteen players injured the left knee and 13 injured the right knee. 
Average age at the time of injury was 26.2 ± 2.8 years (range 21-31, n=24). All injuries 
occurred in game situations. Fifteen (62%) players were injured on Defense, nine (38%) 
on Offense. The most common player position was Linebacker (n=6), followed by 
Defensive End (n=4), Wide Receiver (n=3), Defensive Tackle (n=2), Tight End (n=2), 
Quarterback (n=2), Offensive Lineman (n=2), Defensive Back (n=1), Cornerback (n=1), 
and Safety (n=1). [Table 1] The mechanism of knee injury was shearing blow to the 
playing surface in 22 cases (81%) and direct blow from another player in 5 cases (19%). 
No players were wearing knee pads at the time of injury. 
 
The average time from injury to evaluation by the head team physician and training staff 
was 3.0 ± 4.9 days (range 0-15, n=27). Eighteen knees (67%) were evaluated on the day 
of the injury. Nine knees (33%) were not evaluated on the day of injury, but were 
evaluated when the player later presented for evaluation in the training room with 
complaints of thigh and knee pain, ecchymosis, swelling and stiffness. One player 
reported being aware of a small fluid collection in his distal thigh for 15 days, but only 
sought medical attention after a direct blow from the playing surface created the 
sensation of the fluid “spreading” proximally and laterally in his subcutaneous tissues. 
Sixteen (59%) of the knees had full active range-of-motion upon evaluation while 11 
(41%) were limited in flexion only. Of the 11 knees limited in active flexion, the average 
loss of flexion was 28 ± 15.2 degrees (range 10-45) in 5 cases, and could not be assessed 
secondary to pain with flexion in 6 cases.  
 
When questioned, all players reported tightness in the anterior thigh with increasing knee 
flexion beyond 90 degrees, regardless of the flexion deficit present.  All players were 
found to have varying degrees of thigh and knee swelling, ecchymosis and palpable 
extraarticular suprapatellar fluctuance upon initial evaluation. All players were fully-
weightbearing upon initial evaluation. Physical examination did not demonstrate any 
laxity to ligamentous stress testing in any knees. Radiographs were not routinely 
obtained. MRI of the knee was obtained in two cases. [Figures 1-7]  
 
All knees were treated initially with ice, compression wrap on the thigh and knee, and 
immediate active and passive range-of-motion exercises for the hip and knee. In more 
recent cases, players were also treated with a vasopneumatic cryotherapy device (Game 
Ready Inc., Berkeley, CA). For all knees, the average time for resolution of the fluid 
collection in the MLL, as verified by palpation and inspection, and achievement of full 
active knee flexion was 16.3 ± 18.0 days (range 2-93, n=27). The average number of 
practices missed was 1.5 ± 1.5 (range 0-5, n=27). The average number of games missed 
was 0.1 ± 0.3 (range 0-1, n=27). 
 
Fourteen knees (52%) were treated successfully with cryotherapy, compression wrap, and 
motion exercises alone. In this subset, the average time of resolution of the fluid 
collection in the MLL and achievement of full active knee flexion was 10.6 ± 9.2 days 
(range 2-29, n=14). The average number of practices missed was 1.0 ± 1.2 (range 0-3, 
n=14). There were no games missed.  
 
Thirteen knees (48%) were treated with at least one aspiration. The average number of 
total aspirations in this subset was 2.7 ± 3.1 (range 1-12, n=13). Six knees (22%) were 
treated with multiple aspirations, which were performed over an average of 23.7 ± 28.5 
days (range 5-80, n=6). Aspiration of the MLL was routinely performed under sterile 
conditions in the peripheral region of the area of palpable fluctuance in the thigh or 
suprapatellar region, using a 14 gage needle. The fluid was found to be serosanguinous or 
bloody in all cases and was not routinely sent for culture or hematologic analysis. The 
average amount of fluid yielded was 46 ± 29 ml (range 12-120, n=13 knees) from the 
first aspiration, and 77 ± 53 ml (range 48-300, n=20 aspirations in 6 knees) for each 
subsequent aspiration. Players whose knees were aspirated missed an average of 2.0 ± 1.6 
practices (range 0-5, n=13) and 0.2 ± 0.4 games (range 0-1, n=13). [Table 2] There were 
no infections or adverse affects observed after any aspiration.  
 
In three cases (11%), the MLL was treated with Doxycycline sclerodesis. In each of these 
injuries the sclerodesis was performed after three aspirations failed to resolve the 
recurrent fluid collections associated with the MLL. When performing the sclerodesis, 
the lesion was first aspirated using a 14 gage needle, under sterile conditions, thereby 
evacuating the cavity.  The needle was then left in place as the syringe was removed, and 
100 mg of Doxycycline reconstituted in 5 ml of sterile injectable normal saline 
(20mg/ml) was injected into the MLL using a new syringe. The knee was subsequently 
wrapped with a compressive bandage. All three players returned immediately to play and 
had no fluid collections recur thereafter. There were no infections or adverse affects 
observed after any of the sclerodesis procedures. 
 
 
 
Discussion 
 
We have observed that MLL of the knee in football universally occurs from a direct 
shearing blow. The vast majority of these injuries occurred when the knee struck the 
playing surface. None of the players injured were wearing knee pads, suggesting a 
possible protective roll with their use. The MLL did not always manifest itself 
immediately and was often discounted by players, as demonstrated by the average time of 
3 days between injury and evaluation by the medical staff. In cases of delayed diagnosis, 
an insidious progression of fluid accumulation resulted in progressive swelling, 
ecchymosis and thigh tightness with knee flexion, prompting the player to seek 
evaluation. In our experience, making the diagnosis and distinguishing MLL of the knee 
from prepatellar bursitis and quadriceps contusion can be done by taking a careful history 
and performing a thorough examination. The diagnosis of MLL can be confirmed with 
ultrasound, CT or MRI, although imaging was not typically necessary in our 
experience.26-29  
 
The hallmark physical examination finding of MLL of the knee is a large suprapatellar 
area of palpable fluctuance, often extending to the mid-thigh medially and laterally. 
Decreased cutaneous sensation can also be observed in the skin overlying the lesion. 
Chronic accumulation of lymph fluid that possesses low coagulation properties and high 
molecular concentration has been shown to occur in the potential space of a MLL.22 
When present, we observed these large subcutaneous fluid collections to be up to 300cc 
in size and located in the suprapatellar region and mid-thigh, indicating involvement of 
an area distinct from the prepatellar bursa. In an anatomic dissection study of the 
prepatellar soft tissues of 61 cadaver knees, Dye et al demonstrated that 93% of 
specimens had three specific spaces anterior to the patella that could be termed bursae, 
and potentially be involved in prepatellar bursitis.6 None of these bursae were found to 
extend to the mid-coronal plane medially or laterally, or to the mid-thigh proximally. In 
our limited use of MRI in the management of MLL of the knee, the fluid collections were 
present between the subcutaneous fat and underlying quadriceps fascia, with peripheral 
extension to the mid-coronal plane and mid-thigh. This area of extension was well 
beyond the region of the prepatellar bursae, and would not be consistent with prepatellar 
bursitis. 
 
Diaz et al reported on severe quadriceps muscle contusions in three athletes, two of 
which were professional football players.5 Physical examination consistently 
demonstrated diffuse swelling of the thigh, which was typically tense. Neither diffuse 
ecchymosis nor a focal area of palpable fluctuance was present.  In all three cases MRI 
demonstrated hematoma and edema within one single muscle belly of the vastus 
musculature; this presentation clearly differs from MRI findings in MLL of the knee, 
where the fluid collection is superficial to the vastus fascia, and the underlying 
quadriceps musculature is normal.  
 
Invasive treatment of MLL of the hip region was initially proposed in order to prevent 
potential bacterial superinfection and subsequent chronic recurrent fluid 
accumulations.34,35  Hak et al reported on 24 patients with MLLs over the greater 
trochanter, in the flank and in the lumbodorsal region.11 The lesions were treated with 
serial open debridement and left open to heal by secondary intention. Cultures from the 
closed internal degloving injury were positive in 11 of 24 cases (46%); the incidence of 
positive cultures was not dependent on the time from injury to debridement. This 
aggressive approach was effective, but is not practical for the elite contact athlete who 
desires expeditious return to play with minimal residual functional deficit. 
 
Harma et al described the treatment of five MLLs located in the flank, buttock and gluteal 
regions with compressive elastic bandages or corsets.12 One patient was aspirated because 
of a wide fluctuating lesion; the culture was negative but the lesion recurred early. All 
lesions eventually healed between 4 to 12 weeks without any infections or necrosis. 
Compressive bandages were recommended as treatment for MLL without a large 
associated fluid collection. Similarly, over half (52%) of our players with MLL of the 
knee were treated successfully with compression wrapping alone, in an average of 
approximately 10 days. These lesions likely represented the less severe variants in our 
study, with relatively small fluid collections present. 
 
The Football players who sustained a MLL of the knee with a large fluid collection posed 
a unique challenge. Our treatment goals of resolution of the fluid collection, prevention 
of recurrent fluid collection, achievement of full active knee flexion, and rapid return to 
play were challenged by the likelihood that compression wrapping alone would be 
ineffective, particularly in the short term.  In these cases we elected to perform aspiration 
of the fluid collection followed by compressive wrapping, although minimally invasive 
surgical drainage is an alternative approach that we did not utilize. We chose not to 
perform open drainage initially, but regarded that treatment option as a last resort, given 
the need for hospitalization, prolonged suction drainage, and an extended treatment 
course. However, that method has been proven to be effective in the hip region, and could 
theoretically be utilized in a MLL of the knee when not dealing with an elite contact 
athlete who desires rapid return to play. 
 
Tseng and Tornetta reported on the percutaneous management of 19 patients with MLLs 
in the region of the greater trochanter; 15 had associated pelvic or acetabular fractures.34 
Drainage was performed through two to three 2-cm incisions at the periphery of the 
lesions. A plastic brush was used to debride the injured fatty tissue, which was washed 
from the wound with plastic lavage. A Hemovac drain was placed within the lesion and 
was removed when drainage was less than 30ml over twenty-four hours, which occurred 
between 3 and 8 days later in. A cephalosporin was administered intravenously while the 
drain was in place, and for twenty-four hours after in was removed.  Three of 19 patients 
had positive wound cultures necessitating specific antibiotic therapy. No patient required 
subsequent debridement of skin, and, at a minimum of six months, no deep infection had 
occurred. No later recurrent fluid collections were reported in any patients, suggesting 
success with this method of treatment.  
 
The first player we diagnosed with a MLL of the knee required 13 aspirations prior to 
successful resolution of his recurrent fluid collections; sclerodesis was not attempted at 
that time as we were yet to gain familiarity with that technique. Five subsequent players 
required multiple aspirations for resolution of their lesions. Additionally, one player 
reported a unique history of being struck in the region of an existing MLL of the knee, 
which caused a sensation of fluid spreading to the proximal and lateral thigh; this was 
consistent with further peripheral delamination of the subcutaneous fat from the 
underlying fascia with expansion of the potential space of the lesion. Our desire to more 
effectively treat these challenging cases stimulated our interest in sclerodesis.  
 
Luria et al reported the use of sterile talc sclerodesis to treat posttraumatic pseudocysts 
secondary to persistent MLLs in four patients.22 The patients ranged in age from 20 to 73 
and had pseudocysts in the thigh and buttocks for an average of three months. Under 
fluoroscopic guidance a 12-French pigtail catheter was placed percutaneously in the 
pseudocyst cavity. Contrast was injected to delineate the cavity, and the cavity fluid was 
subsequently suctioned and cultured. Five grams of sterile talc diluted in 50ml of sterile 
saline were then introduced into the lesions and removed after 5 minutes. Compressive 
dressing and continuous wall suction was applied. When drainage was less than 150 ml a 
day, a bulb vacuum drainage system was applied, for an average of 12 days. All 
persistent pseudocysts showed cessation of fluid accumulation in the treated space 
without recurrence, suggesting overall efficacy of this treatment method. There was one 
infection which necessitated IV antibiotics and a second administration of talc 12 days 
after the first treatment due to persistent drainage. 
 
Sclerodesis is a treatment also commonly employed in the treatment of malignant pleural 
effusions. Instillation of compounds including bleomycin, tetracycline, doxycycline or 
talc have been used to cause pleural scarring, thereby preventing fluid recurrent 
accumulation and associated cardio-pulmonary complications. No significant adverse 
effects have been noted, and permanent control of effusions can be achieved in a majority 
of cases.8,10,17,30,31,36  While previously performed through a thoracostomy, talc 
pleurodesis is now safely and effectively performed thoracoscopically.8,17 Both 
tetracycline and doxycycline have also been safe and highly effective in sclerosis of 
malignant pericardial effusions and benign lymphoepithelial cysts of the parotid gland, 
suggesting that application to a MLL could yield similar results.4,7,23,24 
 
The MLL typically contains serosanguinous fluid comprised of blood, lymph and 
necrotic fat. These characteristics are similar to those of lymphoceles, which have been 
successfully treated with percutaneous sclerotherapy in numerous institutions; 
tetracycline, doxycycline, talc, bleomycin, povidone-iodine, ethanol and fibrin glue have 
all been safe and effective.1,2,3,9,15,16,25,32,33  Caliendo et al reported on 21 postoperative 
lymphoceles that were treated with doxycycline sclerotherapy.1 These cystic collections 
of lymph fluid were first treated with percutaneous tube drainage for an average of 11 
days. Once drainage had ceased to less than 30 ml per day and CT or ultrasound had 
demonstrated near complete or total resolution of the lymphocele, 500 mg of doxycycline 
combined with 5ml of 1% lidocaine was instilled into the cavity with a syringe, after any 
excess fluid was first removed through the tube. After one hour the sclerosing agent was 
aspirated from the cavity and the tube was removed. Primary success was achieved in 17 
of 21 cases. Three of four recurrent lymphoceles were treated successfully with repeat 
drainage and sclerotherapy, while one lymphocele underwent successful surgical repair. 
There were no complications related to doxycycline sclerosis. Similarly, we treated three 
cases of recalcitrant fluid collections secondary to unresolved MLL of the knee with 
doxycycline sclerodesis. There were no subsequent recurrent fluid collections or adverse 
affects, and each player was able to return to play without any further time missed.  
Based on data available in the treatment of lymphoceles, there are likely multiple 
alternatives to doxycycline for use in sclerodesis of the MLL. 
 
In conclusion, during the evaluation of a contact athlete who suffers a shearing knee 
injury, one must include MLL in the differential diagnosis. The MLL, distinct from 
prepatellar bursitis and quadriceps contusion, is a delamination of the skin and 
subcutaneous fat from the underlying quadriceps fascia, with rupture of the perforating 
vessels. Large, recurrent fluid collections can occur in the potential space created. In 
addition to direct blow, the history may reveal an insidious accumulation of fluid and 
progressive difficulty with knee flexion. Delayed diagnosis is not uncommon. The 
hallmark examination finding is a suprapatellar area of palpable fluctuance, with 
extension into the thigh. While MRI is not necessary for the diagnosis, it 
characteristically demonstrates subcutaneous fluid extending to the mid-coronal plane 
and mid-thigh, beyond the area of the prepatellar bursae. In cases with small fluid 
collections and full range-of-motion, we recommend a compressive wrap, vasopneumatic 
cryotherapy and immediate motion exercises with an emphasis on knee flexion. In cases 
with large fluid collections and loss of active knee flexion, we recommend attempting up 
to 3 aspirations as needed; compression wrapping and vasopneumatic cryotherapy should 
also be used. If serial aspiration is unsuccessful, doxycycline sclerodesis can be safely 
performed. We did not observe any bacterial infection in MLL of the knee and do not 
believe fluid culture or antibiotic therapy is required for successful treatment. In general, 
the elite contact athlete can be expected to return to play long before resolution of the 
MLL. Further delamination and lesion expansion secondary to contact is a risk with 
return to play prior to complete resolution of the MLL. Knee padding may have a role in 
the prevention of MLL in football. 
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Tables 
 
TABLE 1: Case distribution of MLL of the knee from 1993 to 2006, by player position. 
 
Position Cases 
Linebacker 6 
Defensive End 4 
Wide Receiver 3 
Defensive Tackle 2 
Tight End 2 
Quarterback 2 
Offensive Lineman 2 
Defensive Back 1 
Cornerback 1 
Safety 1 
  
 
TABLE 2: Treatment outcome as expressed in days to lesion resolution, practices missed 
and games missed for all players with a MLL of the knee, players treated without 
aspiration, and players treated with aspiration. 
 
  ALL NO ASPIRATION  ASPIRATION 
OUTCOME (n=27) (n=14) (n=13) 
Days to Resolution 16.3 ± 18.0 10.6 ± 9.2 23.7 ± 28.5 
Practices Missed 1.5 ± 1.5 1.0 ± 1.2 2.0 ± 1.6 
Games Missed 0.1 ± 0.3 0 ± 0 0.2 ± 0.4 
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